Novartis' Zolgensma Under Fire Again as Nature Retracts 2010 Paper

Novartis' gene therapy Zolgensma is again under a cloud of doubt after Nature Biotechnology retracted a 2010 article featuring early data on the treatment over data manipulation concerns.